PHI with Neurogenic post-traumatic bone atrophy
How does this condition affect your private health insurance?
Neurogene posttraumatische Knochenatrophie, commonly known as Sudeck's atrophy or Complex Regional Pain Syndrome (CRPS) Type I, is a severe, chronic pain condition developing in a limb after injury or trauma. It is characterized by intense, disproportionate pain, swelling, changes in skin temperature/color, and significant bone demineralization (atrophy) in the affected area. The pathophysiology involves complex interactions between the nervous system, inflammatory responses, and vascular changes. This condition can lead to severe functional impairment, muscle wasting, joint stiffness, and profound psychological distress. Early recognition and aggressive, multidisciplinary treatment are vital for managing symptoms and improving long-term outcomes, as delayed intervention often leads to permanent disability.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically weeks to months, often persisting if not managed effectively.
Duration of Illness (Lifetime)
Can be chronic and lifelong for a significant percentage of patients, even with treatment.
Cost of Treatment (Initial)
Moderate to high, including diagnostics, specialist consultations, medication, and initial physical therapy.
Cost of Treatment (Lifetime)
Very high for chronic cases, involving ongoing pain management, rehabilitation, psychological support, and potential advanced therapies.
Mortality Rate
Extremely low directly from the condition itself; potential indirect risks due to chronic pain and its psychological impact.
Risk of Secondary Damages
High (60-80%), including chronic pain, severe functional impairment, muscle atrophy, joint contractures, psychological distress (depression, anxiety), and irreversible bone changes.
Probability of Full Recovery
Variable, estimated around 20-50% for complete recovery, especially with early and aggressive treatment; many experience residual symptoms.
Underlying Disease Risk
Not an underlying disease that causes it, but psychological comorbidities like depression (30-50%) and anxiety are common due to chronic pain.